Booming Pharma Sector in India
Single User PDF Format: US$ 1100.00
Multi-User License: US$ 2000.00
Hard Copy: US$ 1300.00
CD-ROM: US$ 1300.00
Pharmaceuticals has emerged as one of the leading industries in the Indian Inc., with the domestic market showing an unprecedented growth of around 9% to generate revenue of about INR 554.5 Billion (US$ 11.1 Billion) in FY 2009. This dramatic growth in the Indian pharmaceutical industry can be attributed to several factors such as growing middle class population, rapid urbanization, increase in lifestyle-related diseases and acceptance of health insurance. Besides, the product patent regime has provided ample support to the industry to sustain its growth pace despite the global economic downturn. Generic is emerging as one of the leading segments to be benefited by many drugs going off-patent in due course of time.
According to our new research report “Booming Pharma Sector in India”, the Indian pharmaceutical industry is projected to show double-digit growth in near future owing to rise in pharmaceutical outsourcing and consolidation of highly fragmented industry. As exports form major part of the pharmaceutical industry in India, leading players have started expanding their reach towards the West. Thanks to investments in R&D and thriving for more and more ANDA filings, the clinical trials market is expected to grow at blistering pace in coming years. To support this evidence, we have done an extensive research and analysis of various segments of the Indian pharmaceutical market. These segments include: Domestic & Export Market, Branded & Generics Drugs, Formulations & Bulk Drugs, etc.
The baseline for optimistic future outlook of the pharmaceutical market is improvement in access to medicines of Indian population. Emerging sectors like biogenerics and pharma packaging will also pave the way for the pharmaceutical market to continue its upward trend over the forecast period (FY 2010- FY 2013).
The report provides thorough statistical and analytical overview of the Indian pharmaceutical market. It contains information about past, present and future trends, with focus on entire structure, composition and working of the pharmaceutical market. The report extensively discusses opportunities and challenges expected to arise within and outside the pharmaceutical market. The report also analyzes emerging sectors, regulatory environment and distribution system to identify strength and weaknesses of the pharmaceutical market. It has thoroughly examined current market trends, industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. It also gives a brief overview of demographics and healthcare profile to adjudge the pharmaceutical market in terms of demand, expenditure and possible future direction.
Multi-User License: US$ 2000.00
Hard Copy: US$ 1300.00
CD-ROM: US$ 1300.00
Pharmaceuticals has emerged as one of the leading industries in the Indian Inc., with the domestic market showing an unprecedented growth of around 9% to generate revenue of about INR 554.5 Billion (US$ 11.1 Billion) in FY 2009. This dramatic growth in the Indian pharmaceutical industry can be attributed to several factors such as growing middle class population, rapid urbanization, increase in lifestyle-related diseases and acceptance of health insurance. Besides, the product patent regime has provided ample support to the industry to sustain its growth pace despite the global economic downturn. Generic is emerging as one of the leading segments to be benefited by many drugs going off-patent in due course of time.
According to our new research report “Booming Pharma Sector in India”, the Indian pharmaceutical industry is projected to show double-digit growth in near future owing to rise in pharmaceutical outsourcing and consolidation of highly fragmented industry. As exports form major part of the pharmaceutical industry in India, leading players have started expanding their reach towards the West. Thanks to investments in R&D and thriving for more and more ANDA filings, the clinical trials market is expected to grow at blistering pace in coming years. To support this evidence, we have done an extensive research and analysis of various segments of the Indian pharmaceutical market. These segments include: Domestic & Export Market, Branded & Generics Drugs, Formulations & Bulk Drugs, etc.
The baseline for optimistic future outlook of the pharmaceutical market is improvement in access to medicines of Indian population. Emerging sectors like biogenerics and pharma packaging will also pave the way for the pharmaceutical market to continue its upward trend over the forecast period (FY 2010- FY 2013).
The report provides thorough statistical and analytical overview of the Indian pharmaceutical market. It contains information about past, present and future trends, with focus on entire structure, composition and working of the pharmaceutical market. The report extensively discusses opportunities and challenges expected to arise within and outside the pharmaceutical market. The report also analyzes emerging sectors, regulatory environment and distribution system to identify strength and weaknesses of the pharmaceutical market. It has thoroughly examined current market trends, industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. It also gives a brief overview of demographics and healthcare profile to adjudge the pharmaceutical market in terms of demand, expenditure and possible future direction.
1. ANALYST VIEW
2. MARKET DRIVERS
2.1 Macroeconomic & Demographic Profile
2.2 Product Patent Regime
2.3 Medical Infrastructure
2.4 Prevalence of Lifestyle-related Diseases
3. INDIAN PHARMACEUTICAL MARKET
3.1 Market Overview
3.2 Domestic & Exports Market
3.3 Future Outlook
4. BRANDED & GENERICS
5. MARKET SEGMENTATION BY TYPE OF DRUGS
5.1 Bulk Drugs/APIs
5.2 Formulations
6. THERAPEUTICS
6.1 Acute Segment
6.1.1 Anti-Infectives
6.1.2 Gastrointestinal
6.1.3 Vitamins/Minerals/Nutrients
6.1.4 Pain/Analgesics
6.1.5 Dermatology
6.1.6 Gynecology
6.1.7 Respiratory
6.2 Chronic Segment
6.2.1 Cardiac
6.2.2 Neuro/CNS
6.2.3 Anti-Diabetic
7. DISTRIBUTION CHANNEL ANALYSIS OF INDIAN PHARMACEUTICAL INDUSTRY
8. REGULATORY OVERVIEW
8.1 Industry Regulations
8.2 Government Initiatives
9. EMERGING SECTORS
9.1 Biogenerics
9.2 Pharma Outsourcing Market
9.3 Bioinformatics
9.4 Clinical Trials
9.5 Pharma Packaging Industry
10. INDUSTRY RESTRAINTS & RNCOS RECCOMENDATIONS
10.1 Counterfeit Drugs
10.2 Drug Price Controls & Low Margins
10.3 Per Capita Spending on Drugs
10.4 Investments & R&D
11. COMPETITIVE LANDSCAPE
11.1 Market Structure
11.2 M&A’s & Industry Developments
11.3 Key Players Analysis
11.3.1 Ranbaxy Laboratories Limited
11.3.2 Cipla Limited
11.3.3 GlaxoSmithKline Pharmaceuticals Limited
11.3.4 Nicholas Piramal India Limited
11.3.5 Zydus Cadila
2. MARKET DRIVERS
2.1 Macroeconomic & Demographic Profile
2.2 Product Patent Regime
2.3 Medical Infrastructure
2.4 Prevalence of Lifestyle-related Diseases
3. INDIAN PHARMACEUTICAL MARKET
3.1 Market Overview
3.2 Domestic & Exports Market
3.3 Future Outlook
4. BRANDED & GENERICS
5. MARKET SEGMENTATION BY TYPE OF DRUGS
5.1 Bulk Drugs/APIs
5.2 Formulations
6. THERAPEUTICS
6.1 Acute Segment
6.1.1 Anti-Infectives
6.1.2 Gastrointestinal
6.1.3 Vitamins/Minerals/Nutrients
6.1.4 Pain/Analgesics
6.1.5 Dermatology
6.1.6 Gynecology
6.1.7 Respiratory
6.2 Chronic Segment
6.2.1 Cardiac
6.2.2 Neuro/CNS
6.2.3 Anti-Diabetic
7. DISTRIBUTION CHANNEL ANALYSIS OF INDIAN PHARMACEUTICAL INDUSTRY
8. REGULATORY OVERVIEW
8.1 Industry Regulations
8.2 Government Initiatives
9. EMERGING SECTORS
9.1 Biogenerics
9.2 Pharma Outsourcing Market
9.3 Bioinformatics
9.4 Clinical Trials
9.5 Pharma Packaging Industry
10. INDUSTRY RESTRAINTS & RNCOS RECCOMENDATIONS
10.1 Counterfeit Drugs
10.2 Drug Price Controls & Low Margins
10.3 Per Capita Spending on Drugs
10.4 Investments & R&D
11. COMPETITIVE LANDSCAPE
11.1 Market Structure
11.2 M&A’s & Industry Developments
11.3 Key Players Analysis
11.3.1 Ranbaxy Laboratories Limited
11.3.2 Cipla Limited
11.3.3 GlaxoSmithKline Pharmaceuticals Limited
11.3.4 Nicholas Piramal India Limited
11.3.5 Zydus Cadila
LIST OF FIGURES:
Figure 2-1: FDI Inflow (Billion US$), FY 2007 to FY 2010
Figure 2-2: FDI in Pharma Industry (Million US$), FY 2007 & FY 2009
Figure 2-3: Share of Mass & Specialty Therapies in Pharmaceutical Market (2006 & 2015)
Figure 3-1: Pharmaceutical Market (Billion INR), FY 2008 & FY 2009
Figure 3-2: Breakup of Pharmaceutical Market (%), FY 2009
Figure 3-3: Domestic Pharmaceutical Market (Billion INR), FY 2006 to FY 2010
Figure 3-4: Pharmaceutical Exports (Billion INR), FY 2008 to FY 2010
Figure 3-5: Pharmaceutical Exports by Segment (%), FY 2009
Figure 3-6: Forecast for Domestic Pharmaceutical Market (Billion INR), FY 2011 to FY 2013
Figure 4-1: Forecast for Domestic Formulations Market by Drug Category (%), 2015
Figure 5-1: Bulk Drugs Export (Billion INR), FY 2008 to FY 2010
Figure 5-2: Domestic Formulations Market (Billion US$), 2007-2010
Figure 5-3: Formulations Export (Billion INR), FY 2008 to FY 2010
Figure 6-1: Domestic Pharmaceutical Market by Therapeutic Category (%), FY 2010
Figure 6-2: Anti-Infectives Market (Billion INR), FY 2010 & FY 2013
Figure 6-3: Gastrointestinal Drugs Market (Billion INR), FY 2010 & FY 2013
Figure 6-4: Vitamins/Minerals/Nutrients Market (Billion INR), FY 2010 & FY 2013
Figure 6-5: Pain/Analgesics Market (Billion INR), FY 2010 & FY 2013
Figure 6-6: Dermatology Market (Billion INR), FY 2010 & FY 2013
Figure 6-7: Gynecology Market (Billion INR), FY 2010 & FY 2013
Figure 6-8: Number of Asthma Patients (Million), 2005 & 2015
Figure 6-9: Respiratory Drugs Market (Billion INR), FY 2010 & FY 2013
Figure 6-10: Number of Coronary Heart Patients (Million), 2005 & 2015
Figure 6-11: Cardiac Drugs Market (Billion INR), FY 2010 & FY 2013
Figure 6-12: Neuro/CNS Drugs Market (Billion INR), FY 2010 & FY 2013
Figure 6-13: Number of Diabetes Patients (Million), 2005 & 2015
Figure 6-14: Anti-Diabetic Market (Billion INR), FY 2010 & FY 2013
Figure 7-1: Pharmaceutical Distribution Channel
Figure 9-1: Pharma Outsourcing Market (Billion US$), 2007-2009
Figure 9-2: Pharma Outsourcing Market by Segment (%), 2008
Figure 9-3: BioInformatics Market (Billion INR), FY 2005 to FY 2010
Figure 9-4: Bioinformatics Market by Exports & Domestic Consumption (%), FY 2009
Figure 9-5: Number of Clinical Trials (2007-2009)
Figure 9-6: Forecast for Number of Clinical Trials (2010-2012)
Figure 9-7: Clinical Trials by Phase (%)
Figure 9-8: Clinical Trials by Therapy (%)
Figure 9-9: Clinical Research Market (Million US$), 2007-2009
Figure 9-10: Forecast for Clinical Research Market (Million US$), 2010-2012
Figure 9-11: Packaging Industry by Segment (%)
Figure 10-1: Global - Per Head Drug Consumption in Top Pharmaceutical Markets (US$), 2007
Figure 10-2: Global - Share of State & Personal Funding in Top Pharmaceutical Markets (2007)
Figure 10-3: Proportion of Revenue Spent on R&D (%), FY 2009
Figure 11-1: Share of Leading Companies in Domestic Pharmaceutical Market
Figure 2-1: FDI Inflow (Billion US$), FY 2007 to FY 2010
Figure 2-2: FDI in Pharma Industry (Million US$), FY 2007 & FY 2009
Figure 2-3: Share of Mass & Specialty Therapies in Pharmaceutical Market (2006 & 2015)
Figure 3-1: Pharmaceutical Market (Billion INR), FY 2008 & FY 2009
Figure 3-2: Breakup of Pharmaceutical Market (%), FY 2009
Figure 3-3: Domestic Pharmaceutical Market (Billion INR), FY 2006 to FY 2010
Figure 3-4: Pharmaceutical Exports (Billion INR), FY 2008 to FY 2010
Figure 3-5: Pharmaceutical Exports by Segment (%), FY 2009
Figure 3-6: Forecast for Domestic Pharmaceutical Market (Billion INR), FY 2011 to FY 2013
Figure 4-1: Forecast for Domestic Formulations Market by Drug Category (%), 2015
Figure 5-1: Bulk Drugs Export (Billion INR), FY 2008 to FY 2010
Figure 5-2: Domestic Formulations Market (Billion US$), 2007-2010
Figure 5-3: Formulations Export (Billion INR), FY 2008 to FY 2010
Figure 6-1: Domestic Pharmaceutical Market by Therapeutic Category (%), FY 2010
Figure 6-2: Anti-Infectives Market (Billion INR), FY 2010 & FY 2013
Figure 6-3: Gastrointestinal Drugs Market (Billion INR), FY 2010 & FY 2013
Figure 6-4: Vitamins/Minerals/Nutrients Market (Billion INR), FY 2010 & FY 2013
Figure 6-5: Pain/Analgesics Market (Billion INR), FY 2010 & FY 2013
Figure 6-6: Dermatology Market (Billion INR), FY 2010 & FY 2013
Figure 6-7: Gynecology Market (Billion INR), FY 2010 & FY 2013
Figure 6-8: Number of Asthma Patients (Million), 2005 & 2015
Figure 6-9: Respiratory Drugs Market (Billion INR), FY 2010 & FY 2013
Figure 6-10: Number of Coronary Heart Patients (Million), 2005 & 2015
Figure 6-11: Cardiac Drugs Market (Billion INR), FY 2010 & FY 2013
Figure 6-12: Neuro/CNS Drugs Market (Billion INR), FY 2010 & FY 2013
Figure 6-13: Number of Diabetes Patients (Million), 2005 & 2015
Figure 6-14: Anti-Diabetic Market (Billion INR), FY 2010 & FY 2013
Figure 7-1: Pharmaceutical Distribution Channel
Figure 9-1: Pharma Outsourcing Market (Billion US$), 2007-2009
Figure 9-2: Pharma Outsourcing Market by Segment (%), 2008
Figure 9-3: BioInformatics Market (Billion INR), FY 2005 to FY 2010
Figure 9-4: Bioinformatics Market by Exports & Domestic Consumption (%), FY 2009
Figure 9-5: Number of Clinical Trials (2007-2009)
Figure 9-6: Forecast for Number of Clinical Trials (2010-2012)
Figure 9-7: Clinical Trials by Phase (%)
Figure 9-8: Clinical Trials by Therapy (%)
Figure 9-9: Clinical Research Market (Million US$), 2007-2009
Figure 9-10: Forecast for Clinical Research Market (Million US$), 2010-2012
Figure 9-11: Packaging Industry by Segment (%)
Figure 10-1: Global - Per Head Drug Consumption in Top Pharmaceutical Markets (US$), 2007
Figure 10-2: Global - Share of State & Personal Funding in Top Pharmaceutical Markets (2007)
Figure 10-3: Proportion of Revenue Spent on R&D (%), FY 2009
Figure 11-1: Share of Leading Companies in Domestic Pharmaceutical Market
LIST OF TABLES:
Table 2-1: Macroeconomic Overview (2009-2013)
Table 2-2: Demographic Characteristics (2009-2013)
Table 3-1: Top 10 Counties for Exports of Drugs, Pharmaceuticals & Fine Chemicals (Billion INR), FY 2009
Table 8-1: Launch of Patented Drugs by Product & Company
Table 10-1: Counterfeit Drugs in Domestic Pharmaceutical Market
Table 10-2: Price Regulation for Number of Formulation Packs (FY 2006 to FY 2009)
Table 11-1: Key Mergers & Acquisitions in Pharmaceutical Industry
Table 2-1: Macroeconomic Overview (2009-2013)
Table 2-2: Demographic Characteristics (2009-2013)
Table 3-1: Top 10 Counties for Exports of Drugs, Pharmaceuticals & Fine Chemicals (Billion INR), FY 2009
Table 8-1: Launch of Patented Drugs by Product & Company
Table 10-1: Counterfeit Drugs in Domestic Pharmaceutical Market
Table 10-2: Price Regulation for Number of Formulation Packs (FY 2006 to FY 2009)
Table 11-1: Key Mergers & Acquisitions in Pharmaceutical Industry
